Grants Search Results

This grant supports a Clinical Research Coordinator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Adolescent and young adults with cancer (AYAs) represent a unique group of patients that do not do as well on treatment when compared to younger children and older adults. There are many reasons why AYAs do not do as well, which include the specific types of cancers that affect this age group, poor participation in clinical trials, psychosocial challenges of being a teenager with a cancer diagnosis, and the location of cancer treatment. This grant supports the development of an AYA program that will help meet the specific needs of this patient population, with a focus on increased access to clinical trials, to improve overall outcomes.

Adolescent and Young Adult (AYA) patients with cancer form a unique group, different than both little children and older adults with cancer. Historically the AYA cancer population has delayed access to care, delay in diagnosis, inconsistent treatment and follow-up, and decreased participation in clinical trials, often leading to inferior survival and quality of life compared to either younger children or older adults. Stony Brook Cancer Center recently started a formal AYA cancer program, with the goal of providing enhanced care and research for AYA patients. This grant supports a nurse navigator for the AYA program, to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a nurse navigator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

The Jim Brady's St. Baldrick's grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure. This grant is named in honor of the 20th annual head-shaving event at Jim Brady's and to celebrate its many volunteers over the years who have supported the event at the birthplace of St. Baldrick's.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

People between the ages of 15 to 40 years old with cancer have a lot of challenges like having to juggle their cancer diagnoses with their day to day lives - school, a job or family, and even things like going out with friends or keeping up with exercise or hobbies. They can feel isolated, afraid and unaware of new drugs that can help, or could be far away from hospitals that offers treatment through clinical trials. This grant supports an adolescent and young adult patient navigator to help young people address these issues throughout their treatment, get them the help they need and steer them towards newer treatments through trials that may increase their chance of a cure from cancer.

Young adulthood is a time filled with exciting possibilities and also difficult challenges. People at this stage of life may be deciding on or attending school, selecting a career or working hard at their jobs, dating or in a relationship, and may be planning for or raising children. A cancer diagnosis does not fit into these plans and goals. Researchers are finding that the biology of the cancers in people of this age group are different, and increasing data indicates that adult patients with some cancers would benefit by being treated on what are traditionally pediatric therapies. Ochsner's Adolescent and Young Adult (AYA) Cancer and Survivor program is the first and only one of its kind in the region. The team is made up of professionals from pediatric and adult medicine. This program is designed for people between the ages of 15 and 39 years of age with cancer -newly diagnosed, actively in therapy and or cancer survivors. This grant supports a Nurse Coordinator who works with new patients in the combined AYA Cancer and Survivor Clinic, to ensure they have access to the best clinical trials for their cancer.

This grant supports a immunotherapy focused Clinical Research Associate to ensure that more kids can be treated on immunotherapy clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports personnel to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Childhood cancer kills more children each year in the US than any other disease. Upstate Golisano Children's Hospital's mission is to conquer childhood cancer through superior care, research, and comprehensive support. Upstate Golisano Children's Hospital provides the medical expertise for children, adolescents, and young adults in the central New York area. They do this by participating in national treatment trials sponsored by the Children's Oncology Group (COG). This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Pediatric cancer research remains limited by a lack of data sharing. While clinical trials remain the cornerstone of pediatric cancer breakthroughs, a consistent and reliable way to store and share data from these trials is lacking. The University of Chicago Pediatric Cancer Data Commons was established to solve this important problem. Sitting alongside the NCI's Genomic Data Commons, the PCDC serves as a neutral repository for data from clinical trials. This information is first converted into a commons format that is consistent across pediatric cancers. The PCDC allows researchers to search over thousands of patients' data to see quickly what data are available for study. Researchers can then apply for access to data, and the PCDC streamlines the process of requesting and downloading data. Finally, the PCDC connects researchers to other kinds of data, including genomic information so critical to studying pediatric cancer. This grant supports personnel to help build the PCDC, so that researchers can efficiently access data and create new ways to study pediatric cancer.

This grant supports a Clinical Research Nurse to ensure that more kids can be treated on clinical trials, often their best hope for a cure. In the past, children diagnosed with cancer in the Rio Grande Valley had to travel to cities such as Houston or San Antonio to get state-or-the-art treatment through clinical trials. Physicians at the Vannie Cook Clinic in the Rio Grande Valley now have access to the most advanced trials and latest medications through Children’s Oncology Group and other Texas-based clinical trials. This gives patients the opportunity to have the optimal outcome from their cancer therapy. More importantly, parents know that their child is getting the best care available, anywhere. That gives families hope that their child will live a long, healthy life.

The Center for Cancer and Blood Disorders at Phoenix Children's Hospital is the only program in the Southwest offering phase I clinical trials for children with cancer, enabling patients to receive the newest, most promising treatments available. These studies are critical for patients whose cancers cannot be cured by currently available treatments. The Early Drug Development Program Clinical Research Assistant supported by this grant will help to conduct these cutting edge trials.